PBM FACTS
278% HIGHER
U.S. drug prices as compared to other developed countries (source). The US is the only country in the world with PBMs.
80%
of the prescription drug market is controlled by just 3 PBMs (Express Scripts, CVS Caremark & Optum (source)). All 3 of these companies are also in the top 15 of the Fortune 500 list.
1,279%
Increase in prescription drug benefit costs & a 222% increase in patient out-of-pocket costs from 1987-2019 (source).
$120 BILLION
Amount PBMs fail to pass back to customers (source).
$143 BILLION
PBMs reaped in rebates in 2019 - PBMs increase drug costs by nearly 30 percent due to rebates charged to drug manufacturers to remain on their formularies, which added nearly 30 cents per dollar to the price consumers pay for prescriptions (source).
42%
of every dollar spent on brand medicines in the commercial market goes to rebates and fees received by PBMs. The total amount of commercial rebates and fees paid to PBMs reached $72 billion in 2022 (source).
> 300%
Increase over the last decade: PBM profits from fees charged to manufacturers, pharmacies, health insurers, and employers (source​).